Cocrystal Pharma closes $4.7 million registered direct offering
PositiveFinancial Markets

Cocrystal Pharma has successfully closed a registered direct offering, raising $4.7 million. This funding will support the company's ongoing research and development efforts.
Editor’s Note: This funding is significant for Cocrystal Pharma as it enables them to advance their innovative treatments in the healthcare sector. The successful offering reflects investor confidence in the company's potential.
— Curated by the World Pulse Now AI Editorial System